Literature DB >> 20157696

Meta-analysis on insulin treatment for type 2 diabetes: rushed conclusions?

A M Wägner, D Mauricio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20157696     DOI： 10.1007/s00125-010-1678-z

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  7 in total

1.  Pharmacokinetic and pharmacodynamic properties of long-acting insulin analogue NN304 in comparison to NPH insulin in humans.

Authors:  G A Brunner; G Sendhofer; A Wutte; M Ellmerer; B Søgaard; A Siebenhofer; S Hirschberger; G J Krejs; T R Pieber
Journal:  Exp Clin Endocrinol Diabetes       Date:  2000       Impact factor: 2.949

2.  Addition of insulin to oral therapy in type 2 diabetes.

Authors:  Selçuk Dağdelen
Journal:  N Engl J Med       Date:  2008-03-13       Impact factor: 91.245

3.  Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Authors:  A R Jadad; R A Moore; D Carroll; C Jenkinson; D J Reynolds; D J Gavaghan; H J McQuay
Journal:  Control Clin Trials       Date:  1996-02

4.  Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes.

Authors:  Rury R Holman; Kerensa I Thorne; Andrew J Farmer; Melanie J Davies; Joanne F Keenan; Sanjoy Paul; Jonathan C Levy
Journal:  N Engl J Med       Date:  2007-09-21       Impact factor: 91.245

Review 5.  Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses.

Authors:  D S Lasserson; P Glasziou; R Perera; R R Holman; A J Farmer
Journal:  Diabetologia       Date:  2009-07-31       Impact factor: 10.122

6.  Three-year efficacy of complex insulin regimens in type 2 diabetes.

Authors:  Rury R Holman; Andrew J Farmer; Melanie J Davies; Jonathan C Levy; Julie L Darbyshire; Joanne F Keenan; Sanjoy K Paul
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

7.  A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes.

Authors:  J Rosenstock; M Davies; P D Home; J Larsen; C Koenen; G Schernthaner
Journal:  Diabetologia       Date:  2008-01-16       Impact factor: 10.122
  7 in total
  1 in total

1.  Comparative efficacy and safety of long-acting insulin analogs in patients with type 2 diabetes failing on oral therapy: Systemic review and meta-analyses.

Authors:  Yan Bi; Xiubin Li; Daizhi Yang; Yuantao Hao; Hua Liang; Dalong Zhu; Jianping Weng
Journal:  J Diabetes Investig       Date:  2012-06-06       Impact factor: 4.232
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.